Franco Maggiolo
About
Franco Maggiolo is a scholar working on Infectious Diseases, Virology and Emergency Medicine.
According to data from OpenAlex, Franco Maggiolo has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in Franco Maggiolo's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (11 papers). Franco Maggiolo is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (11 papers). Franco Maggiolo collaborates with scholars based in Italy, United Kingdom and United States. Franco Maggiolo's co-authors include Sherene Min, Catherine Granier, Brian Wynne, Antonio Antela, Nathan Clumeck, Uriel Sandkovsky, Keith A. Pappa, Garrett Nichols, Dan Duiculescu and Laurent Hocqueloux and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Infectious Diseases.
In The Last Decade
Franco Maggiolo
27 papers receiving 1.3k citations
Hit Papers
Peers
Franco Maggiolo
Clare Brennan United States
Giuliano Rizzardini Italy
Peter Gute Germany
Paul A. Pham United States
Paola Meraviglia Italy
Martin S. Rhee United States
Marshall W. Fordyce United States
Elena Seminari Italy
Herman G. Sprenger Netherlands
Cynthia Brinson United States
Citations per year, relative to Franco Maggiolo Franco Maggiolo (= 1×)
peers
Clare Brennan
Countries citing papers authored by Franco Maggiolo
Since
Specialization
Citations
This map shows the geographic impact of Franco Maggiolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Maggiolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Maggiolo more than expected).
Fields of papers citing papers by Franco Maggiolo
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Franco Maggiolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Maggiolo. The network helps show where Franco Maggiolo may publish in the future.
Co-authorship network of co-authors of Franco Maggiolo
This figure shows the co-authorship network connecting the top 25 collaborators of Franco Maggiolo. A scholar is included among the top collaborators of Franco Maggiolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Maggiolo. Franco Maggiolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mondi, Annalisa, Alessandro Cozzi‐Lepri, Alessandro Tavelli, et al.. (2019). Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort. Journal of the International AIDS Society. 22(1). e25227–e25227.
2.
Wohl, David A., Amanda Clarke, Franco Maggiolo, et al.. (2018). Patient-Reported Symptoms Over 48 Weeks Among Participants in Randomized, Double-Blind, Phase III Non-inferiority Trials of Adults with HIV on Co-formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Co-formulated Abacavir, Dolutegravir, and Lamivudine. Patient. 11(5). 561–573.
3.
Costarelli, Silvia, Alessandro Cozzi‐Lepri, Giuseppe Lapadula, et al.. (2016). Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice. PLoS ONE. 11(10). e0160761–e0160761.
4.
Lichtner, Miriam, Paola Cicconi, Serena Vita, et al.. (2014). Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients. The Journal of Infectious Diseases. 211(2). 178–186.
5.
Costarelli, Silvia, Alessandro Cozzi‐Lepri, Giuseppe Lapadula, et al.. (2014). Co‐administration of ritonavir‐boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice. Journal of the International AIDS Society. 17(4S3). 19571–19571.
6.
Cozzi‐Lepri, Alessandro, Andrea Antinori, Stefano Bonora, et al.. (2014). An observational comparison of first‐line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV‐infected patients in Italy. Journal of the International AIDS Society. 17(4S3). 19771–19771.
7.
Walmsley, Sharon, Antonio Antela, Nathan Clumeck, et al.. (2013). Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection. New England Journal of Medicine. 369(19). 1807–1818.
8.
Maggiolo, Franco & Claudia Bernardini. (2013). Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection. Patient Preference and Adherence. 7. 531–531.
9.
Lichtner, Miriam, Paola Cicconi, Salvatore De Vita, et al.. (2012). CMV co‐infection and risk of AIDS and non‐AIDS events in a large cohort of HIV‐infected patients. Journal of the International AIDS Society. 15(S4). 1–1.
10.
Biagio, Antonio Di, Roberta Prinapori, Diana Giannarelli, et al.. (2012). Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort. Journal of Antimicrobial Chemotherapy. 68(1). 200–205.
11.
Vescini, Fabio, Alessandro Cozzi‐Lepri, Marco Borderi, et al.. (2011). Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(2). 163–172.
12.
Lunzen, Jan van, Franco Maggiolo, José Ramón Arribas, et al.. (2011). Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. The Lancet Infectious Diseases. 12(2). 111–118.
13.
Torti, Carlo, Giuseppe Lapadula, Andrea Antinori, et al.. (2009). Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts. Infection. 37(3). 244–249.
14.
Saracino, Annalisa, Laura Monno, Carmine Tinelli, et al.. (2009). Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients. Current HIV Research. 7(4). 425–433.
15.
Cattaneo, Dario, Franco Maggiolo, D. Ripamonti, & Norberto Perico. (2008). Determination of Atazanavir in Human Plasma by High-Performance Liquid Chromatography With UV Detection. Journal of Chromatographic Science. 46(6). 485–489.
16.
Torti, Carlo, Giuseppe Lapadula, Pablo Barreiro, et al.. (2007). CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. Journal of Antimicrobial Chemotherapy. 59(6). 1141–1147.
17.
Ripamonti, Diego, María Rízzí, Franco Maggiolo, Claudio Arici, & Fredy Suter. (2003). Resolution of Lymphocytic Interstitial Pneumonia in a Human Immunodeficiency Virus-infected Adult Following the Start of Highly Active Antiretroviral Therapy. Scandinavian Journal of Infectious Diseases. 35(5). 348–351.
18.
Maggiolo, Franco, et al.. (2000). Effects of Subinhibitory Concentrations of Moxifloxacin in anIn-VitroDynamic Model. Journal of Chemotherapy. 12(2). 129–133.
19.
Baldanti, Fausto, Stefania Paolucci, Renato Maserati, et al.. (2000). Higher Short-Term Virologic Efficacy of Three-Class Versus Two-Class Highly Active Antiretroviral Salvage Therapy in HIV-Infected Patients. European Journal of Clinical Microbiology & Infectious Diseases. 19(5). 380–384.
20.
Maggiolo, Franco, et al.. (1993). Bactericidal activity of two different dosage regimens of imipenem in an in-vitro dynamic model. Journal of Antimicrobial Chemotherapy. 32(2). 295–300.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Clare Brennan Breakdown of academic impact, for papers by Giuliano Rizzardini Breakdown of academic impact, for papers by Peter Gute Breakdown of academic impact, for papers by Paul A. Pham Breakdown of academic impact, for papers by Paola Meraviglia Breakdown of academic impact, for papers by Martin S. Rhee Breakdown of academic impact, for papers by Marshall W. Fordyce Breakdown of academic impact, for papers by Elena Seminari Breakdown of academic impact, for papers by Herman G. Sprenger Breakdown of academic impact, for papers by Cynthia Brinson